Management of CMV retinal detachments in the new era of antiretroviral therapy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In the past, retinal detachment occurred at a rate of 38% after one year of cytomegalovirus retinitis (CMVR). The current rate of detachment may be reduced by improved therapies for CMVR. In addition, the number of new patients acquiring CMVR has fallen, resulting in a lower incidence of these detachments. Another important effect of the new era of antiviral therapy on CMVR-related detachments includes longer patient survival with a need to select surgical strategies that will provide the best long-term visual outcome while still recognizing the unique difficulties posed by detachments in necrotic retinas. Vitrectomy with planned removal of silicone oil, scleral buckle, vitrectomy with gas tamponade, and laser demarcation are strategies that may provide excellent visual and anatomic results for retinal detachments with various characteristics. The final selection of the surgical approach depends on the mechanical factors of the detachment and patient factors such as immune status, expected survival, control of retinitis, and visual needs.

Original languageEnglish
Pages (from-to)205-213
Number of pages9
JournalOcular Immunology and Inflammation
Volume7
Issue number3-4
StatePublished - Dec 1 1999

Fingerprint

Cytomegalovirus Retinitis
Retinal Detachment
Vitrectomy
Silicone Oils
Retinitis
Survival
Gas Lasers
Therapeutics
Antiviral Agents
Retina
Incidence

Keywords

  • AIDS
  • CMV retinitis
  • Laser demarcation
  • Retinal detachment
  • Silicone oil

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this

Management of CMV retinal detachments in the new era of antiretroviral therapy. / Davis, Janet L.

In: Ocular Immunology and Inflammation, Vol. 7, No. 3-4, 01.12.1999, p. 205-213.

Research output: Contribution to journalArticle

@article{60cc3d8f6b044cce88dbad168ad812c6,
title = "Management of CMV retinal detachments in the new era of antiretroviral therapy",
abstract = "In the past, retinal detachment occurred at a rate of 38{\%} after one year of cytomegalovirus retinitis (CMVR). The current rate of detachment may be reduced by improved therapies for CMVR. In addition, the number of new patients acquiring CMVR has fallen, resulting in a lower incidence of these detachments. Another important effect of the new era of antiviral therapy on CMVR-related detachments includes longer patient survival with a need to select surgical strategies that will provide the best long-term visual outcome while still recognizing the unique difficulties posed by detachments in necrotic retinas. Vitrectomy with planned removal of silicone oil, scleral buckle, vitrectomy with gas tamponade, and laser demarcation are strategies that may provide excellent visual and anatomic results for retinal detachments with various characteristics. The final selection of the surgical approach depends on the mechanical factors of the detachment and patient factors such as immune status, expected survival, control of retinitis, and visual needs.",
keywords = "AIDS, CMV retinitis, Laser demarcation, Retinal detachment, Silicone oil",
author = "Davis, {Janet L}",
year = "1999",
month = "12",
day = "1",
language = "English",
volume = "7",
pages = "205--213",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "3-4",

}

TY - JOUR

T1 - Management of CMV retinal detachments in the new era of antiretroviral therapy

AU - Davis, Janet L

PY - 1999/12/1

Y1 - 1999/12/1

N2 - In the past, retinal detachment occurred at a rate of 38% after one year of cytomegalovirus retinitis (CMVR). The current rate of detachment may be reduced by improved therapies for CMVR. In addition, the number of new patients acquiring CMVR has fallen, resulting in a lower incidence of these detachments. Another important effect of the new era of antiviral therapy on CMVR-related detachments includes longer patient survival with a need to select surgical strategies that will provide the best long-term visual outcome while still recognizing the unique difficulties posed by detachments in necrotic retinas. Vitrectomy with planned removal of silicone oil, scleral buckle, vitrectomy with gas tamponade, and laser demarcation are strategies that may provide excellent visual and anatomic results for retinal detachments with various characteristics. The final selection of the surgical approach depends on the mechanical factors of the detachment and patient factors such as immune status, expected survival, control of retinitis, and visual needs.

AB - In the past, retinal detachment occurred at a rate of 38% after one year of cytomegalovirus retinitis (CMVR). The current rate of detachment may be reduced by improved therapies for CMVR. In addition, the number of new patients acquiring CMVR has fallen, resulting in a lower incidence of these detachments. Another important effect of the new era of antiviral therapy on CMVR-related detachments includes longer patient survival with a need to select surgical strategies that will provide the best long-term visual outcome while still recognizing the unique difficulties posed by detachments in necrotic retinas. Vitrectomy with planned removal of silicone oil, scleral buckle, vitrectomy with gas tamponade, and laser demarcation are strategies that may provide excellent visual and anatomic results for retinal detachments with various characteristics. The final selection of the surgical approach depends on the mechanical factors of the detachment and patient factors such as immune status, expected survival, control of retinitis, and visual needs.

KW - AIDS

KW - CMV retinitis

KW - Laser demarcation

KW - Retinal detachment

KW - Silicone oil

UR - http://www.scopus.com/inward/record.url?scp=0033371764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033371764&partnerID=8YFLogxK

M3 - Article

C2 - 10611729

AN - SCOPUS:0033371764

VL - 7

SP - 205

EP - 213

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 3-4

ER -